Jupiter Life Line Hospitals Schedules Board Meeting on May 15, 2026 to Review Q4FY26 Results and Consider Share Split

Jupiter Life Line Hospitals Limited has informed the stock exchanges of a board meeting scheduled for Friday, May 15, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will take up several significant agenda items, including the review of audited financial results, a dividend declaration, and a share split proposal.

Key Agenda Items

The board meeting has been convened to consider a range of important corporate matters. The following table summarises the key agenda items scheduled for deliberation:

Agenda Item: Details Financial Results: Audited Standalone and Consolidated results for Q4 and FY ended March 31, 2026 Interim Dividend: Consideration and declaration of interim dividend on equity shares for FY 2025-26 Share Split Proposal: Sub-division/split of equity shares with face value of Rs. 10 each, fully paid up Record Date (Dividend): Friday, May 22, 2026

Interim Dividend and Record Date

In terms of Regulation 42 of the Listing Regulations, the company has set Friday, May 22, 2026 as the record date for determining shareholders entitled to receive the interim dividend for FY 2025-26, if declared by the Board of Directors. The dividend, if approved, will be paid on equity shares of the company.

Equity Share Split Proposal

The board will also consider a proposal for the sub-division/split of existing equity shares having a face value of Rs. 10 each, fully paid up. The manner of the split will be determined by the Board of Directors, subject to approval of the shareholders of the company and other requisite regulatory approvals.

Trading Window Closure

In accordance with the Company's Code of Conduct for Prevention, Regulation, Monitoring and Reporting of Insider Trading under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for all Designated Persons and their Immediate Relatives until 48 hours from the conclusion of the board meeting.

The intimation has been filed with the National Stock Exchange of India Ltd. and BSE Limited, and will also be made available on the company's website at www.jupiterhospital.com , pursuant to Regulation 46(2) of the Listing Regulations. The notice was signed by Suma Upparatti, Company Secretary & Compliance Officer, on May 11, 2026.

Jupiter Life Line Hospitals Limited has announced an Earnings Conference Call for investors and analysts, scheduled for Monday, May 18, 2026, at 10:30 AM IST. The announcement was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed with the stock exchanges on May 11, 2026.

Conference Call Details

The call will focus on the company's operational and financial performance for Q4 & FY26. It will be represented by Dr. Ankit Thakker, Joint Managing Director and CEO, along with the Senior Management team. Investors and analysts are requested to pre-register for the call in advance.

The following table outlines the key details of the earnings conference call:

Parameter: Details Event: Earnings Conference Call – Q4 & FY26 Date: Monday, May 18, 2026 Time: 10:30 AM IST Representative: Dr. Ankit Thakker, Joint MD & CEO Regulation: SEBI LODR Regulation 30

Access Information

Participants may join the call using the access numbers provided below:

Access Type: Details Primary Number: +91 22 6280 1309 Primary Number: +91 22 7115 8210 USA Toll Free: 18667462133 UK Toll Free: 08081011573 Singapore Toll Free: 8001012045 Hong Kong Toll Free: 800964448

The investor relations coordination for the call is being managed by Strategic Growth Advisors Pvt. Ltd., with contacts Mandar Chavan and Rahul Agarwal reachable at mandar.chavan@sgapl.net and rahul.agarwal@sgapl.net , or at 9699382195 and 9821438864 respectively.

Regulatory Filing

The intimation was submitted to both the National Stock Exchange of India Ltd. and BSE Limited on May 11, 2026. The filing was signed by Suma Upparatti, Company Secretary & Compliance Officer of Jupiter Life Line Hospitals Limited. The details of the conference call will also be made available on the company's official website at www.jupiterhospital.com .

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.